@aorchid

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).

, , , , , , , , , , , , , , , , , , , and . Clin Infect Dis, 44 (10): 1289--1297 (May 2007)

Description

see page 93 of notebook 00002. so basically no benefit of the higher dose, more toxicity. Overall was comparable to vori efficacy as seen in Herbrecht2002a.

Links and resources

Tags